A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy.

@article{Tisdale2010ARC,
  title={A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy.},
  author={James E. Tisdale and Heather A. Wroblewski and Donna S Wall and Karen M. Rieger and Zane Hammoud and Jerry V Young and Kenneth A. Kesler},
  journal={The Journal of thoracic and cardiovascular surgery},
  year={2010},
  volume={140 1},
  pages={
          45-51
        }
}
OBJECTIVE Atrial fibrillation is common after esophagectomy. The objective of this study was to determine the efficacy and safety of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. METHODS Eighty patients undergoing transthoracic esophagectomy were randomly, prospectively assigned to receive amiodarone (n = 40) or no prophylaxis (control group, n = 40). Amiodarone-treated patients received the drug by continuous infusion, initiated at the time of induction… Expand
Amiodarone for prevention of atrial fibrillation following esophagectomy.
TLDR
Prophylactic intravenous amiodarone is associated with a reduction in the incidence of AF following esophagectomy, but is not associated with shorter postoperative length of hospital stay. Expand
Diltiazem Prophylaxis for the Prevention of Atrial Fibrillation in Patients Undergoing Thoracoabdominal Esophagectomy: A Retrospective Cohort Study
TLDR
A prophylactic 14-day postoperative course of diltiazem was not associated with a reduction in new-onset atrial fibrillation or 30-day mortality following thoracoabdominal esophagectomy and was associated with drug-related adverse effects such as bradycardia and increased requirement of norepinephrine. Expand
Science snippets. Atrial fibrillation prophylaxis, disparity in MTM services eligibility, and point-of-care risk screening.
  • L. Ried
  • Medicine
  • Journal of the American Pharmacists Association : JAPhA
  • 2010
TLDR
Amiodarone appears to provide a safe and effective treatment for this procedure, and no study has evaluated the efficacy of pharmacologic prophylaxis of AF in a noncardiac thoracic surgical population consisting solely of patients undergoing esophagectomy. Expand
Preventing Postoperative Atrial Fibrillation After Noncardiac Surgery: A Meta-analysis.
TLDR
Pharmacologic prophylaxis with amiodarone, beta-blockers, or statins reduces the incidence of postoperative atrial fibrillation after noncardiac surgery. Expand
Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients
TLDR
Postoperative AF is associated with the use of a colon conduit for reconstruction after esophagectomy and with tachycardia with a heart rate >100 bpm on postoperative day (POD) 1. Expand
Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution’s experience
TLDR
Postoperative atrial fibrillation was found to increase ICU length of stay as well as overall length of hospital stay and preoperative amiodarone administration displayed a trend toward decreasing the rates of atrialfibrillation in patients undergoing TEEM. Expand
Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy.
TLDR
The moderate discriminative ability of predictive modelling does not support the use of prophylactic anti-arrhythmic drugs following oesophagectomy, however, the high incidence of AF after major thoracic surgery makes it necessary to understand its underlying mechanisms better. Expand
The predictive value of new-onset atrial fibrillation on postoperative morbidity after esophagectomy.
TLDR
In patients who underwent esophagectomy, new-onset AF was highly associated with infectious complications and may serve as an early clinical warning sign for anastomotic leakage, and further evaluation of patients who develop new-ONSet AF after esophageal cancer is warranted. Expand
Prevalence and risk factors of atrial fibrillation during lung and esophageal surgery
TLDR
Alcohol consumption, history of chemotherapy, and high heart rate during 1-lung ventilation were the risk factors related to intraoperative AF during noncardiac thoracic surgery. Expand
Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
  • R. Day, D. Jaroszewski, +5 authors K. Harold
  • Medicine
  • Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
  • 2016
TLDR
AF did result in an increased length of stay but was not a predictor of other short-term morbidities including anastomotic leak, pulmonary complications, stenosis, or 60-day mortality. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
TLDR
Amiodarone prophylaxis significantly reduces the incidence of AF after anatomic pulmonary resection, and is associated with a significant reduction in length of intensive care unit stay. Expand
Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
TLDR
This double-blind, randomized study assessed the use of preoperative amiodarone as prophylaxis against atrial fibrillation after cardiac surgery and found that patients in the amodarone group were hospitalized for significantly fewer days than those in the placebo group. Expand
Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial.
TLDR
Low-dose i.v. amiodarone was safe and effective in reducing the incidence of atrial fibrillation after heart surgery, but did not significantly alter length of hospital stay. Expand
Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection.
TLDR
LDOA prophylaxis significantly reduces the incidence of atrial fibrillation after pulmonary resection and may be cost-effective in this population of patients 60 years or older. Expand
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
TLDR
Oral amiodarone prophylaxis of atrial tachyarrhythmias after cardiac surgery is effective and may be safe overall and in important patient subgroups. Expand
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial
TLDR
Oral amiodarone prophylaxis in combination with beta-blockers prevents atrial fibrillation and symptomatic fibrilation and reduces the risk of cerebrovascular accidents and ventricular tachycardia. Expand
Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality.
TLDR
Atrial fibrillation is a surrogate for surgical morbidity and mortality after esophagectomy and should prompt not only the appropriate management of the arrhythmia but also a search for a more ominous underlying cause. Expand
Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery.
TLDR
A randomized, double-blind, placebo controlled trial of propranolol for 5 days was undertaken in patients undergoing major thoracic operations to determine whether arrhythmias requiring treatment could be reduced. Expand
Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy.
TLDR
Serum amiodarone concentrations were significantly lower (and in some cases undetectable) when the drug was administered via a nasogastric tube into the stomach conduit in patients after esophagectomy compared with those concentrations after oral administration in a PR population. Expand
Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery.
TLDR
Prospective data support an important role for stress-mediated autonomic mechanisms in the pathogenesis of AF after major thoracic surgery and whether WBC elevations on postoperative day one can help further risk stratify patients younger than 60 years or those with the highest risk who could benefit from one or more AF prevention strategies. Expand
...
1
2
3
...